Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption — Stella

Home/Migraine/Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

View on ClinicalTrials.gov

Recruiting

Back to Migraine trials

Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption

Trial locations(1 site)

Spain

Hospital Clínico Universitario de Valladolid, Valladolid

Key details

Sponsor

Hospital Clínico Universitario de Valladolid

Enrollment target

~200 participants

Started

February 2022

Primary completion

February 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.